Welcome to the official website of Xi'an Maishang Biotechnology Co., Ltd
Home
About
Company Profile
Maishang Culture
Organizational Structure
Honor
Service Area
Maishang
Mai sike
News
Maishang News
Industry News
Enterprise Announcement
Memorabilia
Contact Us
Report Interpretation
Talent recruitment
Contact
——
Employee World
Reproductive genetic testing project
Although the 'Year of the Snake' that many investors had hoped for did not start well, the correction in the market could not stop the sudden rise of the pharmaceutical sector. Last week, pharmaceutical stocks dominated, and the stock prices of many companies in the sector reached historic highs.
14
2023
/
06
Opinions of the State Council on Implementing the Healthy China Action(Guo Fa[2019]No.13)
After the establishment of the People's Republic of China,especially since the reform and opening up,China's health industry has made significant progress,and the main health indicators of residents are generally better than the average level of middle-income countries.With the acceleration of industrialization,urbanization,and population aging,the production,lifestyle,and disease spectrum of Chinese residents are constantly changing.Chronic non communicable diseases such as cardio cerebral Vascular disease,cancer,chronic Respiratory disease,diabetes and other chronic non communicable diseases accounted for 88%of the total deaths,and the resulting Disease burden accounted for more than 70%of the total disease burden.The awareness rate of residents'health knowledge is relatively low,and unhealthy lifestyles such as smoking,excessive alcohol consumption,lack of exercise,and unreasonable diet are more common,resulting in increasingly prominent disease problems.The situation of prevention and control of major infectious diseases such as hepatitis,tuberculosis and AIDS is still grim,and problems in mental health,occupational health and endemic diseases cannot be ignored
The National Development and Reform Commission issued the"14th Five Year Plan"Bioeconomy Development Plan
Currently,cutting-edge research in the field of life sciences continues to be active,and the wave of biotechnology revolution has swept the world and accelerated its integration into economic and social development,providing new solutions for humanity to address major challenges such as life and health,climate change,resource and energy security,and food security.The Outline of the 14th Five Year Plan clearly proposes to promote the integration and innovation of biotechnology and information Technological convergence,accelerate the development of biomedicine,biological breeding,biomaterials,Bioenergy and other industries,and make the Bioeconomy bigger and stronger.In order to thoroughly implement the decisions and arrangements of the CPC Central Committee and the State Council,scientifically plan and systematically promote the high-quality development of Bioeconomy in China,the National Development and Reform Commission has issued the 14th Five Year Bioeconomy Development Plan(hereinafter referred to as the"Plan")with the approval of the State Council
Notice on Further Strengthening Drug Safety Management and Improving the Level of Reasonable Drug Use
Strengthen the implementation of medication safety systems.Medical institutions should improve and implement medication safety related systems,enhance the awareness and ability of medical and technical personnel to prevent medication errors,and implement the full process management of prescription issuance,dispensing,administration,and medication.Physicians should provide correct,standardized,and appropriate prescriptions based on the patient's condition;The pharmacist carefully performs the responsibility of prescription review,and all prescriptions and medication orders are dispensed after being reviewed as qualified;Nurses and other medical personnel who execute medication orders should carefully verify and strictly follow the"three checks and seven checks"to ensure the accuracy of the time,route,dosage,and other aspects of medication administration.Encourage medical institutions to use information technology to intelligently review and manage the entire process of clinical medication
Establishment of the company
Xi'an Meishang Biotechnology Co., Ltd. (hereinafter referred to as "the Company") was founded on March 30, 2017, and is located in West Area, No. 2, Compound 131, Fengcheng 6th Road, Xi'an Economic and Technological Development Zone. The company has a total laboratory area of 1076 square meters under the Xi'an Maishang Medical Laboratory. It is to create a third-party independent medical laboratory in accordance with international standards. With PCR laboratory certification, clinical cell Molecular genetics professional laboratory certification. On November 7, 2019, it obtained the qualification of "medical laboratory". On July 12, 2020, it was approved as a Nucleic acid test laboratory in Shaanxi Province, and in December of the same year, it was approved as an isolation point Nucleic acid test institution.
30
2017
03
Geneva Gold Award Certificate
12
Silver Award at the 2016 Geneva International Invention Exhibition-Based on Artificial Intelligence Fetal Monitoring System
Special Special Award
Business Consulting
Please fill in the questions you need to inquire about, and we will provide corresponding services according to your needs!